Contribution of Planar (0–1 Ortho) and Nonplanar (2–4 Ortho) Fractions of Aroclor 1260 to the Induction of Altered Hepatic Foci in Female Sprague–Dawley Rats
- 15 December 2000
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 169 (3) , 255-268
- https://doi.org/10.1006/taap.2000.9058
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs.Environmental Health Perspectives, 1999
- Altered function, localization and phosphorylation of gap junctions in rat liver epithelial, IAR 20, cells after treatment with PCBs or TCDDEnvironmental Toxicology and Pharmacology, 1997
- Species-specific antagonism of Ah receptor action by 2,2′,5,5′-tetrachloro- and 2,2′,3,3′,4,4′-hexachlorobiphenylEuropean Journal of Pharmacology: Environmental Toxicology and Pharmacology, 1995
- Interaction of 3,4,5,3′,4′‐Pentachlorobiphenyl and 2,4,5,2′,4′,5′‐Hexachlorobiphenyl in Promotion of Altered Hepatic Foci in RatsBasic & Clinical Pharmacology & Toxicology, 1995
- Toxic equivalency factors for dioxin-like PCBsChemosphere, 1994
- Modeling Receptor‐Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk AssessmentRisk Analysis, 1993
- The determination of chlorinated biphenyls, chlorinated dibenzodioxins, and chlorinated dibenzofurans by GC‐MSJournal of High Resolution Chromatography, 1992
- Preparative fractionation of a commercial PCB productChemosphere, 1991
- 2,2′,4,4′,5,5′-Hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL6J miceToxicology and Applied Pharmacology, 1989
- Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxinArchives of Toxicology, 1988